STAT+: FDA moves to ease path for biosimilars as Trump seeks to cut drug costs
WASHINGTON — The Trump administration announced a draft framework Wednesday that officials say will speed cheaper versions of biologic drugs ...
WASHINGTON — The Trump administration announced a draft framework Wednesday that officials say will speed cheaper versions of biologic drugs ...
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech ...
President Trump described his administration’s agreement with Pfizer on several drug pricing plans as a historic measure to lower costs ...
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech ...
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Dear Readers, The news seems unrelenting these days, and when it comes to health and medicine, it’s all the more ...
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign ...
Tara Bannow covers hospitals, providers, and insurers. You can reach Tara on Signal at tarabannow.70.WASHINGTON — Last week’s pledge from ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.